These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 9191383

  • 1. Cellular and humoral responses to microencapsulated Yersinia pestis subunit vaccines following oral delivery.
    Sharp GJ, Eyles JE, Williamson ED, Brown MR, Alpar HO.
    Biochem Soc Trans; 1997 May; 25(2):338S. PubMed ID: 9191383
    [No Abstract] [Full Text] [Related]

  • 2. Cell-mediated immune response and Th/Th cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis.
    Gupta G, Khan AA, Rao DN.
    Scand J Immunol; 2010 Mar; 71(3):186-98. PubMed ID: 20415784
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits.
    Eyles JE, Williamson ED, Spiers ID, Stagg AJ, Jones SM, Alpar HO.
    J Control Release; 2000 Jan 03; 63(1-2):191-200. PubMed ID: 10640592
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The use of inbred mice for studying the protective properties of Yersinia pestis antigens].
    Zadumina SIu, Nazarova LS, Isupov IV, Pavlova LP, Tikhomirova EI.
    Zh Mikrobiol Epidemiol Immunobiol; 1995 Jan 03; (6):69-70. PubMed ID: 8553769
    [No Abstract] [Full Text] [Related]

  • 10. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A, Cohen S, Levy Y, Halperin G, Lazar S, Velan B, Shafferman A, Flashner Y, Mamroud E.
    Vaccine; 2008 Mar 20; 26(13):1616-25. PubMed ID: 18304706
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
    Sabhnani L, Manocha M, Sridevi K, Shashikiran D, Rayanade R, Rao DN.
    FEMS Immunol Med Microbiol; 2003 Oct 15; 38(3):215-29. PubMed ID: 14522457
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Local and systemic immune response to a microencapsulated sub-unit vaccine for plague.
    Williamson ED, Sharp GJ, Eley SM, Vesey PM, Pepper TC, Titball RW, Alpar HO.
    Vaccine; 1996 Dec 15; 14(17-18):1613-9. PubMed ID: 9032889
    [Abstract] [Full Text] [Related]

  • 20. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.
    Glynn A, Roy CJ, Powell BS, Adamovicz JJ, Freytag LC, Clements JD.
    Infect Immun; 2005 Aug 15; 73(8):5256-61. PubMed ID: 16041052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.